Abstract
Since the late 1960s, a number of retrospective trials have reported an increased survival among patients with ischemic heart disease and hypertension treated with β-blockers [1–5]. However, these trials are all exposed to the drawbacks and dangers of retrospective observations. A number of prospective trials have been planned and carried out. The purpose of the present paper is to review the published findings. Special attention will be paid to the major points of criticism often raised in connection with the respective trials, in an effort to prepare a rationale for our clinical management of patients today.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Amsterdam EA, Wolfson S, Garlin R (1968) Effect of therapy on survival in angina pectoris. Ann Intern Med 68: 1151
Lambert DMD (1979) Hypertension and myocardial infarction. Br Med J 3: 685–686
Lambert DMD (1974) Hypertension and myocardial infarction. Br Med J: 685–686
Lambert DMD (1976) Effect of propranolol on mortality in patients with angina. Postgrad Med J [Suppl] 52: 57–60
Stewart I, McDG (1976) A prospective study of the comparative incidence of myocardial infarction in essential uncomplicated hypertensives under treatment containing or excluding a β-adrenergic blocking agent. In: Fourth meeting of the international society of hypertension [Abstr]
Reynolds JL, Whitlock RML (1972) Effects of β-adrenergic receptor blocker in myocardial infarction treated for one year from onset. Br Heart J 34: 252–259
Barber JM, Boyle DM, Chatuverdi NC, Singh N, Walsh MJ (1975) Practolol in acute myocardial infarction. Acta Med Scand [Suppl] 587: 213–216
Wilcox RG, Roland JM, Banks DC, Hampton JRA (1980a) Randomised trial comparing atenolol with propranolol in immediate treatment of suspected myocardial infarction. Br Med J 1: 885–888
Wilcox RG, Rowley JM, Hampton JR, Mitchel JRA, Roland JM, Banks DC (1980) Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet II: 765–769
Wilhelmsson C, Vedin A, Wilhelmsen L, Tibblin G, Werkö L (1971) Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet II: 1157–1160
Vedin A, Wilhelmsson C, Werkö L (1975) Alprenolol after myocardial infarction. Acta Med Scand [Suppl] 575: 1–56
Ahlmark G, Saetre H (1976) Long-term treatment with β-blockers after myocardial infarction. Eur J. Clin Pharmacol 10: 77–83
Vedin A, Wilhelmsson C, Tibblin G, Wilhelmsen L (1976) The post-infarction clinic in Goteborg, Sweden. A controlled trial of a therapeutic organisation. Acta Med Scand 200: 453–456
A Multicentre International Study (1975) Improvement in prognosis of myocardial infarction by long-term β-adrenoceptor blockade using practolol. Br Med J 1: 735–740
Andersen M, Bechsgaard P, Fredriksen J et al. (1979) The effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Lancet II: 865–868
Norwegian Study Group (1981) Timolol-indiced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304: 801–807
Baber NS, Wainwright-Evans D, Howitt G et al. (1980) Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy and Yugoslavia. Br Heart J 44: 96–100
Mitchell JRA (1981) Timolol after myocardial infarction: An answer or a new set of questions. Br Med J 282: 1565–1570
Wilhelmsson C, Vedin A, Wilhelmsen L (to be published) Cost-benefit aspects of post- myocardial infarction intervention. Acta Med Scand [Suppl]
Vedin A, Wilhelmsson C (1981) Secondary prevention trials: a review of β-blocker trials. In: Julian O (ed) Comparative β blockade and the ischemic myocardium, pp 63–76
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Vedin, A. (1982). Secondary Prevention Trials with β-Blocking Drugs After Myocardial Infarction. In: Lang, E., Sörgel, F., Blaha, L. (eds) Beta-Blockers in the Elderly. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68674-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-68674-0_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-11682-0
Online ISBN: 978-3-642-68674-0
eBook Packages: Springer Book Archive